Catalyst Wire Dossier Catalyst Wire Dossier

Remimazolam Tosylate

remimazolam tosylate · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Remimazolam Tosylate, covering 2018-02-23 to 2018-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers [Phase 1]

See pricing